SCM
ONC

Superstring Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Superstring Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,365
Closed -$1.18M – 53
2024
Q4 		$1.18M Buy
+6,365
New +$1.3M 1.02% 25
2024
Q3 		– Sell
-12,508
Closed -$1.78M – 45
2024
Q2 		$1.78M Buy
+12,508
New +$1.93M 2.25% 12

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Superstring Capital Management's ONC Position: Q1 2025 in Review

Superstring Capital Management sold out of BeOne Medicines Ltd (ONC) in Q1 2025, closing a stake of 6,365 shares — an estimated $1.18M sold.

Superstring Capital Management first reported a position in ONC in Q2 2024 and held it in 2 quarters. The position peaked at $1.78M in Q2 2024. 266 funds tracked by Wall St. Rank hold ONC as of Q1 2025.

  • Superstring Capital Management reported no remaining BeOne Medicines Ltd position as of Q1 2025 after selling out during the quarter.
  • Superstring Capital Management sold 6,365 BeOne Medicines Ltd shares in Q1 2025, an estimated $1.18M.
  • Superstring Capital Management first reported a position in BeOne Medicines Ltd in Q2 2024 and held it in 2 quarters.
  • Superstring Capital Management's BeOne Medicines Ltd position peaked at $1.78M in Q2 2024.
  • 266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2025.

Based on Superstring Capital Management's 13F filing for Q1 2025, filed 15 May 2025.